Dolby Laboratories (DLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 805,593 | 724,045 | 734,866 | 799,786 | 925,250 |
| Marketable Securities | 119,146 | 120,737 | 158,679 | 175,557 | 178,138 |
| Receivables | 189,115 | 231,185 | 178,617 | 181,614 | 166,133 |
| Inventories | 32,331 | 38,908 | 34,632 | 27,765 | 26,206 |
| Other current assets | 195,651 | 182,912 | 244,917 | 199,480 | 165,959 |
| TOTAL | $1,381,540 | $1,338,817 | $1,395,761 | $1,423,803 | $1,496,576 |
| Non-Current Assets | |||||
| PPE Net | 537,432 | 524,641 | 537,641 | 523,193 | 514,182 |
| Investments And Advances | 179,587 | 211,352 | 199,302 | 201,428 | 187,782 |
| Intangibles | 515,720 | 525,240 | 513,750 | 516,332 | 512,001 |
| Other Non-Current Assets | 207,470 | 209,758 | 200,497 | 158,304 | 154,846 |
| TOTAL | $1,440,209 | $1,470,991 | $1,451,190 | $1,399,257 | $1,368,811 |
| Total Assets | $2,821,749 | $2,809,808 | $2,846,951 | $2,823,060 | $2,865,387 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 15,212 | 14,304 | 14,626 | 9,811 | 21,922 |
| Accrued Expenses | 268,144 | 243,738 | 230,708 | 265,091 | 243,128 |
| Other current liabilities | 19,991 | 19,435 | 20,014 | 19,562 | 17,468 |
| TOTAL | $306,853 | $278,339 | $265,450 | $294,585 | $285,198 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 201,849 | 211,130 | 228,509 | 179,382 | 209,548 |
| TOTAL | $201,866 | $211,193 | $228,644 | $179,521 | $209,686 |
| Total Liabilities | $508,719 | $489,532 | $494,094 | $474,106 | $494,884 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 100,201 | 100,770 | 101,650 | 102,617 | 103,263 |
| Common Shares | 99 | 99 | 100 | 101 | 102 |
| Retained earnings | 2,327,877 | 2,328,918 | 2,361,607 | 2,361,843 | 2,313,539 |
| Other shareholders' equity | -14,946 | -8,741 | -8,850 | -12,990 | -9,265 |
| TOTAL | $2,313,030 | $2,320,276 | $2,352,857 | $2,348,954 | $2,370,503 |
| Total Liabilities And Equity | $2,821,749 | $2,809,808 | $2,846,951 | $2,823,060 | $2,865,387 |